市場調查報告書

寡核甘酸合成:全球市場分析·預測 (2019-2029年)

Global Oligonucleotide Synthesis Market: Focus on Products, Applications, End Users, Region/Country Data (17 Region/Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029

出版商 BIS Research Inc. 商品編碼 882257
出版日期 內容資訊 英文 289 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
寡核甘酸合成:全球市場分析·預測 (2019-2029年) Global Oligonucleotide Synthesis Market: Focus on Products, Applications, End Users, Region/Country Data (17 Region/Countries), and Competitive Landscape - Analysis and Forecast, 2019-2029
出版日期: 2019年06月28日內容資訊: 英文 289 Pages
簡介

全球寡核甘酸合成市場到2029年前預計將達到42億9,000萬美元的規模。

本報告提供全球寡核甘酸合成市場調查,提供市場概要,市場成長的各種影響因素及市場機會分析,各市場區隔·各地區的趨勢與市場規模的變化與預測,競爭環境,主要企業的簡介等系統性資訊。

摘要整理

第1章 市場概要

  • 簡介
  • 市場定義
  • 重要的用途
  • 寡核甘酸合成類別
  • 全球足跡

第2章 市場動態

  • 影響分析
  • 市場成長的推動要素
  • 阻礙因素
  • 機會
  • 課題

第3章 競爭情形

  • 主要策略·發展
  • 市場佔有率分析
  • 成長佔有率分析

第4章 產業分析

  • 產業趨勢

第5章 全球寡核甘酸合成市場:各產品

  • 簡介
  • 寡核甘酸合成
  • 設備
  • 試劑
  • 服務

第6章 全球寡核甘酸合成市場:各用途

  • 概要
  • 研究
  • 治療
  • 診斷

第7章 全球寡核甘酸合成市場:各終端用戶

  • 概要
  • 大學研究機關
  • 醫藥品·生物科技企業
  • 診斷實驗室

第8章 全球寡核甘酸合成市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第9章 企業簡介

  • 概要
  • Agilent Technologies
  • ATDBio Ltd.
  • Bio-Synthesis Inc.
  • Eurofins Scientific SE
  • Kaneka Eurogentec S.A.
  • General Electric Company
  • TriLink BioTechnologies, LLC
  • GenScript Biotech Corp
  • Ajinomoto
  • Biolegio B.V.
  • Danaher Corporation
  • Microsynth AG
  • Merck KGaA
  • LGC Limited
  • Thermo Fisher Scientific Inc.

第10章 調查範圍·手法

目錄
Product Code: BH157A

Global Oligonucleotide Synthesis Market to Reach $4.29 Billion by 2029

Key questions answered in this report:

  • How much revenue was generated by the global oligonucleotide synthesis market in 2018 and how is it expected to perform by 2029?
  • What are the major market drivers, opportunities, and challenges present in the global oligonucleotide synthesis market?
  • What are the underlying structures resulting in the emerging trends within the global oligonucleotide synthesis market?
  • What are the key developmental strategies which are implemented by the major players to sustain in the competitive market?
  • Which are the leading players with significant offerings to the global oligonucleotide synthesis market? What is the current market dominance for each of these leading players?
  • How much revenue is expected to be generated by the product segment, which includes synthesized oligonucleotides, equipment, and reagent of the global oligonucleotide synthesis market, during the forecast period from 2019 to 2029?
  • How much revenue is expected to be generated by the application which includes research, therapeutics, and diagnostics of the global oligonucleotide synthesis market, during the forecast period from 2019 to 2029?
  • How much revenue is expected to be generated by the end user which includes academic research institutes, pharmaceutical and biotechnology companies, and diagnostic laboratories of the global oligonucleotide synthesis market, during the forecast period from 2019 to 2029?
  • What is the scope of the global oligonucleotide synthesis market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa? Which product, application, and end-user segment currently dominate these regions?

Global Oligonucleotide Synthesis Market Forecast, 2019-2029

The Global Oligonucleotide Synthesis Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 11.02% during the forecast period from 2019 to 2029.

The oligonucleotide synthesis market growth is majorly driven by factors such as increasing inline and strong pipeline of oligonucleotides, growing consolidation of the market, and increasing burden of cancer and chronic diseases. However, there are significant challenges which are restraining the market growth. These challenges include lack of regulatory scenario for these oligonucleotides, complex therapeutic classification due to wide variety of oligonucleotides, and challenging drug delivery techniques.

Expert Quote on Global Oligonucleotide Synthesis Market

"North America is the leading contributor in the global oligonucleotide synthesis market and contributed approximately 41.5% to the global market value in 2018. This region is anticipated to grow at a CAGR of 10.84% during the forecast period 2019-2029 and continue dominating the global market in 2029 as well. However, the Asia-Pacific region is expected to grow at an impressive CAGR of 11.80% during the forecast period from 2019-2029. The Europe region also contributed a significant share of 28.0% to the global market and is anticipated to grow at a CAGR of 10.73% during the forecast period from 2019-2029."

Scope of the Market Intelligent on the Global Oligonucleotide Synthesis Market

The oligonucleotide synthesis market research provides a detailed perspective regarding the applications of the technology, its value and estimation, among others. The purpose of the study is to gain a holistic view of the global oligonucleotide synthesis market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The report includes an in-depth examination of the key players and recent developments taking place in this market. The research study highlights the factors governing the industry attractiveness with detailed product mapping, market estimation, and analysis of key trends in multiple geographical regions, growth of oligonucleotide synthesis market in each region for different applications, and the key strategies and developments by the prominent oligonucleotide manufacturers.

Market Segmentation

The market has been segmented on the basis of 'products', 'applications', 'end users', and 'regions'.

The oligonucleotide synthesis market segmentation (on the basis of product) is further segmented into primers, probes, large-scale synthesized oligonucleotides, intermediate-scale synthesized oligonucleotides, and linkers and adaptors. Although products are widespread, there is still considerable apprehension toward the adoption of these to stratify research, therapeutics, and diagnostics.

The oligonucleotide synthesis market segmentation (on the basis of applications) is further segmented into diagnostics, therapeutics, and research.

The oligonucleotide synthesis market segmentation (on the basis of end users) is further segmented into academic research institutes, diagnostic laboratories, and pharmaceutical and biotechnology companies. The academic research segment is poised to dominate the oligonucleotide synthesis market by end user, during the forecast period.

The oligonucleotide synthesis market segmentation (on the basis of region) is further segmented into North America, Europe, APAC, Latin America, and Middle East and Africa. The North America oligonucleotide synthesis market is expected to dominate the oligonucleotide synthesis market during the forecast period, 2019-2029.

Key Companies in the Oligonucleotide Synthesis Market

The key manufacturers that have been contributing significantly to the global oligonucleotide synthesis market include Agilent Technologies, ATDBio Ltd., Bio-Synthesis Inc., Eurofins Scientific S.E., Kaneka Eurogentec S.A., GE Healthcare, GenScript Corporation, Ajinomoto Co. Inc., Danaher Corporation, LGC Limited, Merck KGaA, and Thermo Fisher Scientific, among others.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Introduction
  • 1.2 Market Definition
  • 1.3 Significant Applications
  • 1.4 Different Types of Synthesized Oligonucleotides
  • 1.5 Global Footprint

2 Market Dynamics

  • 2.1 Impact Analysis
  • 2.2 Market Drivers
    • 2.2.1 Increasing Inline and Strong Pipeline of Oligonucleotides
    • 2.2.2 Rising Consolidation in the Market
    • 2.2.3 Increasing Incidence of Cancer and Chronic Diseases
  • 2.3 Restraints
    • 2.3.1 Regulatory Complexity
  • 2.4 Opportunity
    • 2.4.1 Positive Future Outlook
    • 2.4.2 Growth in Developing Countries
  • 2.5 Challenges
    • 2.5.1 Difficult Therapeutic Classification Due to Wide Variety of Oligonucleotides
    • 2.5.2 Challenging Drug Delivery

3 Competitive Landscape

  • 3.1 Key Strategies and Developments
    • 3.1.1 Product Launches and Enhancements
    • 3.1.2 Acquisitions
    • 3.1.3 Synergistic Activities
    • 3.1.4 Business Expansion Activities
  • 3.2 Market Share Analysis
  • 3.3 Growth Share Analysis

4 Industry Insights

  • 4.1 Industry Trends
    • 4.1.1 Oligonucleotide Microarray Boosts Market Expansion
    • 4.1.2 Drug Pipeline Analysis
    • 4.1.3 Oligonucleotide Synthesis Down the Line

5 Global Oligonucleotide Synthesis Market, By Product, 2018-2029 ($Million)

  • 5.1 Introduction
  • 5.2 Synthesized Oligonucleotides
    • 5.2.1 Synthesized Oligonucleotides, By Product
      • 5.2.1.1 Primers
      • 5.2.1.2 Probes
      • 5.2.1.3 Large-Scale Synthesized Oligonucleotides
      • 5.2.1.4 Intermediate-scale synthesized oligonucleotides
      • 5.2.1.5 Linkers and Adaptors
    • 5.2.2 Synthesized Oligonucleotides, By Type
    • 5.2.3 Custom Oligonucleotides
    • 5.2.4 Pre-designed oligonucleotides
  • 5.3 Equipment
  • 5.4 Reagent
  • 5.5 Services

6 Global Oligonucleotide Synthesis Market, By Application, 2018-2029 ($Million)

  • 6.1 Overview
  • 6.2 Research
    • 6.2.1 Polymerase Chain Reaction
    • 6.2.2 qPCR
    • 6.2.3 Next-Generation Sequencing
    • 6.2.4 Gene Synthesis
    • 6.2.5 Other Research Application
  • 6.3 Therapeutics
    • 6.3.1 DNA and Antisense Oligonucleotide-Based Therapies
    • 6.3.2 RNA Oligonucleotides Therapies
    • 6.3.3 Other Therapeutic Applications
  • 6.4 Diagnostics

7 Global Oligonucleotide Synthesis Market, By End User, 2018-2029 ($Million)

  • 7.1 Overview
  • 7.2 Academic Research Institutes
  • 7.3 Pharmaceutical and Biotechnology Companies
  • 7.4 Diagnostic Laboratories

8 Global Oligonucleotide Synthesis Market, By Region, 2018-2029 ($Million)

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest-of-Europe
  • 8.4 Asia-Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest-of-Asia-Pacific
  • 8.5 Latin America
  • 8.6 Middle East and Africa

9 Company Profiles

  • 9.1 Overview
  • 9.2 Agilent Technologies
    • 9.2.1 Company Overview
    • 9.2.2 Role of Agilent Technologies in the global oligonucleotide synthesis market
    • 9.2.3 Financials
    • 9.2.4 Key Insights about Financial Health of the Company
    • 9.2.5 SWOT Analysis
  • 9.3 ATDBio Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 Role of ATDBio Ltd. In the global oligonucleotide synthesis market
    • 9.3.3 SWOT Analysis
  • 9.4 Bio-Synthesis Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Role of Bio-Synthesis Inc. in the global oligonucleotide synthesis market
    • 9.4.3 SWOT Analysis
  • 9.5 Eurofins Scientific SE
    • 9.5.1 Company Overview
    • 9.5.2 Role of Eurofins Scientific SE in the global oligonucleotide synthesis market
    • 9.5.3 Financials
    • 9.5.4 SWOT Analysis
  • 9.6 Kaneka Eurogentec S.A.
    • 9.6.1 Company Overview
    • 9.6.2 Role of Kaneka Eurogentec S.A. in the global oligonucleotide synthesis market
    • 9.6.3 SWOT Analysis
  • 9.7 General Electric Company
    • 9.7.1 Company Overview
    • 9.7.2 Role of General Electric Company in the global oligonucleotide synthesis market
    • 9.7.3 Financials
    • 9.7.4 Key Insights about Financial Health of the Company
    • 9.7.5 SWOT Analysis
  • 9.8 TriLink BioTechnologies, LLC
    • 9.8.1 Company Overview
    • 9.8.2 Role of TriLink BioTechnologies, LLC in the global oligonucleotide synthesis market
    • 9.8.3 SWOT Analysis
  • 9.9 GenScript Biotech Corp
    • 9.9.1 Company Overview
    • 9.9.2 Role of GenScript Biotech Corp in the global oligonucleotide synthesis market
    • 9.9.3 Financials
    • 9.9.4 Key Insights about Financial Health of the Company
    • 9.9.5 SWOT Analysis
  • 9.10 Ajinomoto Co., Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Role of Ajinomoto Co., Inc. in the global oligonucleotide synthesis market
    • 9.10.3 Financials
    • 9.10.4 Key Insights about Financial Health of the Company
    • 9.10.5 SWOT Analysis
  • 9.11 Biolegio B.V.
    • 9.11.1 Company Overview
    • 9.11.2 Role of Biolegio B.V. in the global oligonucleotide synthesis market
    • 9.11.3 SWOT Analysis
  • 9.12 Danaher Corporation
    • 9.12.1 Company Overview
    • 9.12.2 Role of Danaher Corporation in the global oligonucleotide synthesis market
    • 9.12.3 Financials
    • 9.12.4 Key Insights about Financial Health of the Company
    • 9.12.5 SWOT Analysis
  • 9.13 Microsynth AG
    • 9.13.1 Company Overview
    • 9.13.2 Role of Microsynth AG in the global oligonucleotide synthesis market
    • 9.13.3 SWOT Analysis
  • 9.14 Merck KGaA
    • 9.14.1 Company Overview
    • 9.14.2 Role of Merck KGaA in the global oligonucleotide synthesis market
    • 9.14.3 Financials
    • 9.14.4 Key Insights about Financial Health of the Company
    • 9.14.5 SWOT Analysis
  • 9.15 LGC Limited
    • 9.15.1 Company Overview
    • 9.15.2 Role of LGC Limited in the global oligonucleotide synthesis market
    • 9.15.3 Financials
    • 9.15.4 Key Insights about Financial Health of the Company
    • 9.15.5 SWOT Analysis
  • 9.16 Thermo Fisher Scientific Inc.
    • 9.16.1 Company Overview
    • 9.16.2 Role of Thermo Fisher Scientific Inc. in the global oligonucleotide synthesis market
    • 9.16.3 Financials
    • 9.16.4 Key Insights about Financial Health of the Company
    • 9.16.5 SWOT Analysis

10 Research Scope and Methodology

  • 10.1 Research Scope
  • 10.2 Global Oligonucleotide Synthesis Market: Research Methodology

List of Tables

  • Table 2.1: Impact Analysis
  • Table 5.1: Global Oligonucleotide Synthesis Market Size, By Product, $Million (2018-2029)
  • Table 5.2: Global Synthesized Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.3: Global Primer Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.4: Global Probes Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.5: Global Large-Scale Synthesized Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.6: Global Intermediate-scale synthesized oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.7: Global Linkers and Adaptors Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.8: Global Custom Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.9: Global Pre-design Oligonucleotides Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.10: Global Oligonucleotide Equipment Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.11: Global Oligonucleotide Reagent Market Size, By Region/Country, $Million (2018-2029)
  • Table 5.12: Global Oligonucleotide Services Market Size, By Region/Country, $Million (2018-2029)
  • Table 6.1: Global Oligonucleotide Synthesis Market, By Application, $Million (2018-2029)
  • Table 6.2: Global Oligonucleotide Synthesis Market for Research, By Type, 2018-2029 ($Million)
  • Table 6.3: Global Oligonucleotide Synthesis Market for Research, By Region/Country, 2018-2029 ($Million)
  • Table 6.4: Global Oligonucleotide Synthesis Market for PCR, By Region/Country, 2018-2029 ($Million)
  • Table 6.5: Global Oligonucleotide Synthesis Market For qPCR, By Region/Country, 2018-2029 ($Million)
  • Table 6.6: Global Oligonucleotide Synthesis Market for NGS, By Region/Country, 2018-2029 ($Million)
  • Table 6.7: Global Oligonucleotide Synthesis Market for Gene Synthesis, By Region/Country, 2018-2029 ($Million)
  • Table 6.8: Global Oligonucleotide Synthesis Market for Other Application, By Region/Country, 2018-2029 ($Million)
  • Table 6.9: Global Oligonucleotide Synthesis Market for Therapeutics, By Type, 2018-2029 ($Million)
  • Table 6.10: Global Oligonucleotide Synthesis Market for Therapeutics, By Region/Country, 2018-2029 ($Million)
  • Table 6.11: Global Oligonucleotide Synthesis Market for Antisense Therapies, By Region/Country, 2018-2029 ($Million)
  • Table 6.12: Global Oligonucleotide Synthesis Market for RNA Oligonucleotide Therapies, By Region/Country, 2018-2029 ($Million)
  • Table 6.13: Global Oligonucleotide Synthesis Market for Other Therapeutic Applications, By Region/Country, 2018-2029 ($Million)
  • Table 6.14: Global Oligonucleotide Synthesis Market for Diagnostics, By Region/Country, 2018-2029 ($Million)
  • Table 7.1: Oligonucleotide Synthesis Market (by End User), 2018-2029, $ Million
  • Table 7.2: Oligonucleotide Synthesis Market for Academic Institutes (by Country/Region), 2018-2029, $Million
  • Table 7.3: Oligonucleotide Synthesis Market for Pharmaceutical and Biotechnology Companies (by Country/Region), 2018-2029 ($ Million)
  • Table 7.4: Oligonucleotide Synthesis Market for Diagnostic Laboratories (by Country/Region), 2018-2029 ($ Million)
  • Table 8.1: Global Oligonucleotide Synthesis Market (by Region), 2018-2029
  • Table 8.2: North America Oligonucleotide Synthesis Market Revenue (by Country), 2018-2029, $Million
  • Table 8.3: North America Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.4: North America Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.5: North America Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.6: North America Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.7: North America Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.8: North America Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.9: North America Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.10: U.S. Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.11: U.S. Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.12: U.S. Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.13: U.S. Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.14: U.S. Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.15: U.S. Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.16: U.S. Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.17: Canada Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.18: Canada Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.19: Canada Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.20: Canada Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.21: Canada Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.22: Canada Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.23: Canada Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.24: Europe Oligonucleotide Synthesis Market Revenue (by Country), 2018-2029, $Million
  • Table 8.25: Europe Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.26: Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.27: Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.28: Europe Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.29: Europe Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.30: Europe Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.31: Europe Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.32: Germany Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.33: Germany Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.34: Germany Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.35: Germany Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.36: Germany Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.37: Germany Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.38: Germany Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.39: U.K. Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.40: U.K. Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.41: U.K. Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.42: U.K. Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.43: U.K. Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.44: U.K. Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.45: U.K. Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.46: France Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.47: France Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.48: France Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.49: France Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.50: France Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.51: France Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.52: France Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.53: Italy Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.54: Italy Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.55: Italy Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.56: Italy Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.57: Italy Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.58: Italy Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.59: Italy Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.60: Spain Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.61: Spain Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.62: Spain Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.63: Spain Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.64: Spain Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.65: Spain Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.66: Spain Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.67: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.68: Rest-of-Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Milli
  • Table 8.69: Rest-of-Europe Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.70: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.71: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.72: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.73: Rest-of-Europe Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.74: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Country), 2018-2029, $Million
  • Table 8.75: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.76: Asia-Pacific Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.77: Asia-Pacific Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.78: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.79: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.80: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.81: Asia-Pacific Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.82: China Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.83: China Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.84: China Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.85: China Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.86: China Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.87: China Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.88: China Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.89: Japan Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.90: Japan Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.91: Japan Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.92: Japan Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.93: Japan Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.94: Japan Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.95: Japan Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.96: India Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.97: India Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.98: India Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.99: India Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.100: India Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.101: India Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.102: India Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.103: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.104: Rest-of-APAC Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.105: Rest-of-APAC Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.106: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.107: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.108: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.109: Rest-of-APAC Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.110: Latin America Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.111: Latin America Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.112: Latin America Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.113: Latin America Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.114: Latin America Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.115: Latin America Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.116: Latin America Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million
  • Table 8.117: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Product), 2018-2029, $Million
  • Table 8.118: Middle East and Africa Synthesized Oligonucleotide Synthesis Market Revenue (by Synthesized Oligonucleotides), 2018-2029, $Million
  • Table 8.119: Middle East and Africa Synthesized Oligonucleotide Synthesis Market Revenue (by Modification Type), 2018-2029, $Million
  • Table 8.120: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Application), 2018-2029, $Million
  • Table 8.121: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Research Application), 2018-2029, $Million
  • Table 8.122: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by Therapeutic Application), 2018-2029, $Million
  • Table 8.123: Middle East and Africa Oligonucleotide Synthesis Market Revenue (by End User), 2018-2029, $Million

List of Figures

  • Figure 1: Impact of Market Drivers and Market Restraints on the Global Oligonucleotide Synthesis Market
  • Figure 2: Global Oligonucleotide Synthesis Market Snapshot
  • Figure 3: Dominant Segments of the Global Oligonucleotide Synthesis Market, 2019 and 2029
  • Figure 4: Global Oligonucleotide Synthesis Market (by Product), 2019 and 2029
  • Figure 5: Global Oligonucleotide Synthesis Market (by Applications), 2019 and 2029
  • Figure 6: Global Oligonucleotide Synthesis Market (by End User), 2019 and 2029
  • Figure 7: Global Oligonucleotide Synthesis Market (by Region), 2019 and 2029
  • Figure 1.1: Global Oligonucleotide Synthesis Market, 2018-2029
  • Figure 2.1: Market Dynamics of Global Oligonucleotide Synthesis Market
  • Figure 3.1: Share of Key Developments and Strategies, (January 2016 - April 2019)
  • Figure 3.2: Product Launches Share (by Companies), January 2016 - April 2019
  • Figure 3.3: Acquisitions Share (by Companies), January 2016 - April 2019
  • Figure 3.4: Synergistic Activities Share (by Companies), January 2016 - April 2019
  • Figure 3.5: Synergistic Activities Share (by Companies), January 2016 - April 2019
  • Figure 3.6: Market Share Analysis for the Global Oligonucleotide Synthesis Market, 2017
  • Figure 3.7: Market Share Analysis for the Global Oligonucleotide Synthesis Market, 2018
  • Figure 3.8: Growth Share Matrix for Global Oligonucleotide Synthesis Market (by Companies), 2018
  • Figure 4.1: Oligonucleotide Drug Clinical Trials Pipeline Analysis, till June 2019 (Industry Sponsored: Active and Completed)
  • Figure 5.1: Oligonucleotide Synthesis Market, by Product, 2019 and 2029 ($Million)
  • Figure 5.2: Synthesized Oligonucleotides Market, by Product, 2019 and 2029 ($Million)
  • Figure 5.3: Synthesized Oligonucleotide Market, by Type, 2019 and 2029 ($Million)
  • Figure 6.1: Oligonucleotide Synthesis Market, by Application, 2019 and 2029 ($Million)
  • Figure 7.1: Oligonucleotide Synthesis Market, by End User, 2019 and 2029 ($Million)
  • Figure 8.1: Oligonucleotide Synthesis Market, by Region, 2019 and 2029 ($Million)
  • Figure 8.2: North America: Market Dynamics
  • Figure 8.3: Projections of the Older Adult Population in the U.S.: 2020 to 2060 (Million)
  • Figure 8.4: Europe: Market Dynamics
  • Figure 8.5: Pharmaceutical R&D Expenditure in Europe, $Million (2015-2017)
  • Figure 8.6: Germany Research Based Pharmaceutical R&D Expenditure, $Billion (2011-2016)
  • Figure 8.7: APAC: Market Dynamics
  • Figure 8.8: Latin America: Market Dynamics
  • Figure 9.1: Total Number of Companies Profiled
  • Figure 9.2: Agilent Technologies: Overall Product Portfolio
  • Figure 9.3: Agilent Technologies: Overall Financials, 2016-2018
  • Figure 9.4: Agilent Technologies: Revenue (by Segment), 2016-2018
  • Figure 9.5: Agilent Technologies: Revenue (by Region), 2016-2018
  • Figure 9.6: Agilent Technologies: R&D Expenditure, 2016-2018
  • Figure 9.7: Agilent Technologies: SWOT Analysis
  • Figure 9.8: ATDBio Ltd.: Overall Product Portfolio
  • Figure 9.9: ATDBio Ltd.: SWOT Analysis
  • Figure 9.10: Bio-Synthesis Inc.: Overall Product Portfolio
  • Figure 9.11: Bio-Synthesis Inc.: SWOT Analysis
  • Figure 9.12: Eurofins Scientific SE: Product Portfolio
  • Figure 9.13: Eurofins Scientific SE: Overall Financials, 2016-2018
  • Figure 9.14: Eurofins Scientific SE: Revenue (by region), 2016-2018
  • Figure 9.15: Eurofins Scientific SE: SWOT Analysis
  • Figure 9.16: Kaneka Eurogentec S.A.: Overall Product Portfolio
  • Figure 9.17: Kaneka Eurogentec S.A.: SWOT Analysis
  • Figure 9.18: GE Healthcare: Overall Product Portfolio
  • Figure 9.19: General Electric Company: Overall Financials, 2016-2018
  • Figure 9.20: General Electric Company: Revenue (by Segment), 2016-2018
  • Figure 9.21: General Electric Company: Revenue Split for Healthcare, 2016-2018
  • Figure 9.22: General Electric: Healthcare Revenue (by Region), 2016-2018
  • Figure 9.23: General Electric Company: R&D Expenditure, 2016-2018
  • Figure 9.24: General Electric Company: SWOT Analysis
  • Figure 9.25: TriLink BioTechnologies, LLC.: Overall Product Portfolio
  • Figure 9.26: TriLink BioTechnologies, LLC: SWOT Analysis
  • Figure 9.27: GenScript Biotech Corp: Overall Product Portfolio
  • Figure 9.28: GenScript Biotech Corp: Overall Financials, 2016-2018
  • Figure 9.29: GenScript Biotech Corp: Revenue (by Segment), 2016-2018
  • Figure 9.30: GenScript Biotech Corp: Revenue (by Region), 2016-2018
  • Figure 9.31: GenScript Biotech Corp: R&D Expenditure, 2016-2018
  • Figure 9.32: GenScript Biotech Corp: SWOT Analysis
  • Figure 9.33: Ajinomoto Co., Inc.: Overall Product Portfolio
  • Figure 9.34: Ajinomoto Co., Inc.: Overall Financials, 2016-2018
  • Figure 9.35: Ajinomoto Co., Inc.: Revenue (by Segment), 2016-2018
  • Figure 9.36: Ajinomoto Co., Inc.: Revenue (by Region), 2016-2018
  • Figure 9.37: Ajinomoto Co., Inc.: R&D Expenditure, 2016-2018
  • Figure 9.38: Ajinomoto Co., Inc.: SWOT Analysis
  • Figure 9.39: Biolegio B.V.: Overall Product Portfolio
  • Figure 9.40: Biolegio B.V.: SWOT Analysis
  • Figure 9.41: Danaher Corporation: Overall Product Portfolio
  • Figure 9.42: Danaher Corporation: Overall Financials, 2016-2018
  • Figure 9.43: Danaher Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 9.44: Danaher Corporation: Revenue (by Region), 2016-2018
  • Figure 9.45: Danaher Corporation: R&D Expenditure, 2016-2018
  • Figure 9.46: Danaher Corporation: SWOT Analysis
  • Figure 9.47: Microsynth AG: Overall Product Portfolio
  • Figure 9.48: Microsynth AG: SWOT Analysis
  • Figure 9.49: Merck KGaA: Overall Product Portfolio
  • Figure 9.50: Merck KGaA: Overall Financials, 2016-2018
  • Figure 9.51: Merck KGaA: Revenue (by Segment), 2016-2018
  • Figure 9.52: Merck KGaA: Revenue (by Region), 2016-2018
  • Figure 9.53: Merck KGaA: R&D Expenditure, 2016-2018
  • Figure 9.54: Merck KGaA: SWOT Analysis
  • Figure 9.55: LGC Limited: Overall Product Portfolio
  • Figure 9.56: LGC Limited: Overall Financials, 2017-2018
  • Figure 9.57: LGC Limited: Revenue (by Segment), 2017-2018
  • Figure 9.58: LGC Limited: Revenue (by Region), 2018
  • Figure 9.59: LGC Limited: R&D Expenditure, 2017-2018
  • Figure 9.60: LGC Limited: SWOT Analysis
  • Figure 9.61: Thermo Fisher Scientific Inc.: Overall Product Portfolio
  • Figure 9.62: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 9.63: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
  • Figure 9.64: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
  • Figure 9.65: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
  • Figure 9.66: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 10.1: Global Oligonucleotide Synthesis Market Segmentation
  • Figure 10.2: Global Oligonucleotide Synthesis Market Research Methodology
  • Figure 10.3: Primary Research
  • Figure 10.4: Secondary Research
  • Figure 10.5: Data Triangulation
  • Figure 10.6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 10.7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 10.8: Assumptions and Limitations
  • Figure 10.9: Considered Factors for Data Prediction and Modelling
Back to Top